SCRI-IS Technologies Ltd. is revolutionizing the pharmaceutical industry with its pioneering sustainable asset reliability solutions. Established in 2018, the Ireland-based company specializes in reliability engineering to support cGMP business operations, focusing on the asset management of elastomers and metals used in drug production systems. Their services include hands-on elastomer/soft parts change-outs, detailed audit-ready reports, material reliability consultancy, failure root cause analysis, and accelerated life testing with a purpose-built, fully automated test skid. This innovative approach aims to help clients avoid loss of system integrity, maximize production yields, and enhance material performance, ultimately benefiting both the business and patients. With a strong emphasis on compliance and efficiency, SCRi-IS Technologies offers a comprehensive suite of services to meet the unique needs of the pharmaceutical industry.
There is no investment information
No recent news or press coverage available for SCRI-IS Technologies Ltd..